Related references
Note: Only part of the references are listed.Therapy-Related Acute Myeloid Leukemia With t(8;21) (q22;q22) Shares Many Features With De Novo Acute Myeloid Leukemia With t(8;21)(q22;q22) but Does Not Have a Favorable Outcome
Steven A. Gustafson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)
Friederike Schneider et al.
BLOOD (2009)
Cytoplasmic Localization of Nucleophosmin in Bone Marrow Blasts of Acute Myeloid Leukemia Patients Is Not Completely Concordant With NPM1 Mutation and Is Not Predictive of Prognosis
Sergej Konoplev et al.
CANCER (2009)
Application of COLD-PCR for improved detection of KRAS mutations in clinical samples
Zhuang Zuo et al.
MODERN PATHOLOGY (2009)
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse
Paolo Sportoletti et al.
BLOOD (2008)
Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions - a review
Paolo Bernasconi
BRITISH JOURNAL OF HAEMATOLOGY (2008)
A new DNA-based test for detection of nucleophosmin exon 12 mutations by capillary electrophoresis
Philippe Szankasi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia
Ulrike Bacher et al.
HAEMATOLOGICA (2007)
NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype
Yue Zhang et al.
LEUKEMIA RESEARCH (2007)
Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes
Harold J. Olney et al.
LEUKEMIA RESEARCH (2007)
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
S Schnittger et al.
BLOOD (2005)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type
WN Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia
LY Shih et al.
LEUKEMIA (2004)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
Share Paper
